Ono Pharmaceutical

Ono to Acquire Deciphera for $2.4 Billion

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer therapeutics, and specializes in kinase biology.

News

Merck Settles Keytruda Patent Disputes

News

Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

Top-Feature

Easyfairs Deutschland GmbH

Brenntag Downsizes Management Board, Retains Both Divisions

Interview

The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Ono Pharmaceutical

Ono to Acquire Deciphera for $2.4 Billion

Merck Settles Keytruda Patent Disputes

Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

Top-Feature

Leading the way. Driving results.

Driving Sustainability Through Collaboration

Anchored in Sustainability

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Leading Transformation

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

API Manufacturing

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

20 Years of CHEManager International

Brenntag Downsizes Management Board, Retains Both Divisions

Interview

Leading Transformation

Newsletter & e-edition